NCT07333469 2026-01-13
A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Phase 1/2 Not yet recruiting
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Biotroy Therapeutics
Princess Maxima Center for Pediatric Oncology
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.